IRNA agents targeting VEGF
US7919473B2 · kind B2 · utility
6Cited by
29References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 25, 2006 |
| Grant date | Apr 5, 2011 |
| Priority date | — |
| Expiry date | Jan 25, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2320/32
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The features of the present invention relate to compounds, compositions and methods useful for modulating the expression of vascular endothelial growth factor (VEGF), such as by the mechanism of RNA interference (RNAi). The compounds and compositions include iRNA agents that can be unmodified or chemically-modified.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.